Halftime Report


  • Investors pile into emerging markets     Friday, 25 Jul 2014 | 12:51 PM ET

    Discussing where ETFs are seeing big inflows, with Stacey Gilbert, Susquehanna Financial Group.

  • Drug costs hit insurers: Gilead still a buy?     Friday, 25 Jul 2014 | 12:15 PM ET

    CNBC's Bertha Coombs reports which insurance stocks are feeling the pressure from high drug costs. FMHR trader Stephen Weiss advises investors to stick with Gilead.

  • Lyft launches Friday night in NYC     Friday, 25 Jul 2014 | 12:08 PM ET

    New York regulators and Lyft have reached a deal, reports CNBC's Morgan Brennan.

  • Have a plan: Pro     Friday, 25 Jul 2014 | 12:30 PM ET

    Discussing the current market environment, and Amazon's performance after disappointing earnings, with Joe Greco, Meridian Equity Partners.

  • FMHR Final Trade: DAL, AAL, MSFT & FSLR     Friday, 25 Jul 2014 | 12:58 PM ET

    The FMHR traders reveal their final trades.

  • Your first trade for Friday Thursday, 24 Jul 2014 | 1:39 PM ET

    The "Fast Money" traders share their final trades of the day.

  • Wall Street's tax question for President Obama     Thursday, 24 Jul 2014 | 12:21 PM ET

    CNBC's Steve Liesman provides a preview of what he'll be asking President Obama when he interviews him on the economy, including his position on tax inversion legislation.

  • Bullish case for Facebook: Pro     Thursday, 24 Jul 2014 | 12:06 PM ET

    Dan Niles, AlphaOne Capital Partners, explains why he thinks Facebook is the best Internet stock. They still haven't scratched the surface of other things they can do, says Niles.

  • Who's afraid of Janet Yellen?     Thursday, 24 Jul 2014 | 12:34 PM ET

    Dan Veru, Palisade Capital Management, explains why he thinks Janet Yellen needs to stay out of portfolio management, and shares his top biotech and small-cap picks.

  • China challenges Caterpillar     Thursday, 24 Jul 2014 | 12:53 PM ET

    The Fast Money team has the play on four stocks making news on Thursday.

  • Futures Now: Chinese gold demand plunges     Thursday, 24 Jul 2014 | 12:28 PM ET

    The Futures Now team discusses how to play the slide in gold prices as demand drops 19 percent in the first half of the year.

  • Tax inversions by the numbers     Thursday, 24 Jul 2014 | 12:20 PM ET

    CNBC's Meg Tirrell crunches the numbers to figure out the cost to the U.S. economy when companies relocate overseas.

  • Herbalife after Ackman     Thursday, 24 Jul 2014 | 12:42 PM ET

    Herb Greenberg, CNBC contributor, provides a reality check on whether or not billionaire investor Bill Ackman actually made his case against Herbalife.

  • Your first trade for Thursday Wednesday, 23 Jul 2014 | 6:00 PM ET

    The "Fast Money" traders share their final trades of the day.

  • Najarian: 'Fishy' options trade ahead of Puma news Wednesday, 23 Jul 2014 | 10:56 AM ET

    Someone bet big in the options market that Puma Biotechnology would be a winner in the days before a positive drug trial sent its stock soaring.

  • Apple preps biggest launch ever: Pro     Wednesday, 23 Jul 2014 | 12:31 PM ET

    Citi's Jim Suva, provides his read on Apple, as the tech giant prepares to debut the iPhone 6. We think this is going to be the best product out there, says Suva.

  • Tech stocks' make-or-break moment     Wednesday, 23 Jul 2014 | 12:07 PM ET
    California tech companies: Apple Inc., Intel Corp, Google Inc. Cisco Inc.

    It's a big week for momentum stocks, reports CNBC's Seema Mody, with a look at tech stocks reporting earnings this week.

  • Airlines set to take off?     Wednesday, 23 Jul 2014 | 12:17 PM ET

    CNBC's Phil LeBeau breaks down the numbers on Delta and Boeing. Also a look at what to expect from the high-flying airline sector as the S&P Transports hit all-time highs for the second day in a row.

  • The timing was very suspicious, says Fast Money's Jon Najarian, with a look at some unusual options activity he spotted in Puma Biotech. And Pete Najarian, explains why he is keeping an eye on Talisman Energy.

  • Biotech blowout: Biogen & Gilead     Wednesday, 23 Jul 2014 | 12:40 PM ET

    CNBC's Dominic Chu takes a look at the big movers in biotech on Wednesday.

Contact Halftime Report

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET

Follow Halftime Report